All In Nutritionals
Home Blog Page 140

Loblaw to spin out its interest in Choice Properties REIT

0
Loblaw to spin out its interest in Choice Properties REIT

Loblaw Companies Ltd. and George Weston Ltd. (GWL) Have announced a reorganization under which Loblaw will spin out its 61.6 per cent interest in Choice Properties REIT.

Under the spin-out, Loblaw common shareholders other than GWL will receive 0.135 of a GWL common share per Loblaw share, which is equivalent to the market value of their pro rata interest in Choice Properties, and GWL will receive Loblaw’s 61.6 per cent interest in Choice Properties.

After the spin-out, Loblaw will not retain any equity interest in Choice Properties and will be a pure-play Canadian food and drug retailer.

“The reorganization will result in a more efficient group structure, that strategically benefits both Loblaw and Choice Properties, which in turn strengthens GWL,” said Galen G. Weston, Chairman and CEO, Loblaw Companies Ltd. and George Weston Ltd.

“Loblaw, Choice Properties and GWL investors will all benefit from the strategic and investment clarity this transaction brings.”

“Over the past few years, the strategies of Loblaw and Choice Properties have diverged. Loblaw is focused on strengthening its core retail business and growing in areas such as digital, healthcare, payments and rewards, while Choice Properties is focused on mixed-use development and investments in diversified real estate asset classes,” said Sarah Davis, President of Loblaw Companies Ltd.

“Our retail store network continues to be a key competitive advantage for us, but we don’t see ownershipof real estate as core to our strategy going forward.”

Loblaw plans to maintain its current quarterly common share dividend after the spin-out. GWL plans to raise its quarterly common share dividend by 5 per cent to $0.515 per share (or $2.06 per share annualized), contingent on the closing of this transaction.

Therefore, aggregating dividends from the two companies, Loblaw shareholders who hold their distributed GWL common shares post-closing of the transaction will receive a 24 per cent increase in their current dividend as a result of the spin-out.

The transaction will have no impact on the important, ongoing operating relationship between Loblaw and Choice Properties and all current agreements and arrangements, including the Strategic Alliance Agreement and leases, will remain in place after the spin-out. In addition, Loblaw will continue to be Choice Properties’ largest tenant.

Loblaw and GWL do not expect any change to the credit ratings of Loblaw, Choice Properties or GWL by Standard and Poor’s or DBRS as a result of the spin-out.

The plan of arrangement will require the approval of at least two-thirds of the votes cast by all the common shareholders of Loblaw, as well as a majority of the votes cast by Loblaw Minority Shareholders. The vote will be conducted at a special meeting of Loblaw shareholders expected to take place in October 2018.

La Coop fédérée Signs an Agreement with W-S Feed & Supplies Ltd

0
La Coop fédérée Signs an Agreement with W-S Feed & Supplies Ltd

La Coop fédérée, a Montreal-based agri-food co-operative with operations across Canada, and W-S Feed & Supplies Ltd., announced today that La Coop fédérée will purchase a 50% stake in the animal nutrition company based in Tavistock, Ont.

W-S Feeds operates two feed mills in Ontario, in Tavistock and Mount Forest. The new partnership will continue to manufacture a wide variety of feeds for dairy production, including organic, beef, swine and poultry production.

“This investment represents a strategic entry into the Ontario market, in the animal nutrition industry this time” says Ghislain Gervais, president of La Coop fédérée. “This partnership develops our portfolio of operations in the province and shows how important it is for us to provide farmers across the country with quality products and solutions for their animal feed,” he adds.

After recently gaining a foothold in the Prairie provinces for its animal feed activities with the acquisition of Standard Nutrition Canada, La Coop fédérée’s Agri-business Division keeps extending this line of business which is already well established in Quebec and the Maritimes. Earlier this year, the Agri-business Division also announced the acquisition of Cargill’s crop input and grain assets in Ontario, a transaction pending the approval of Canada’s Competition Bureau.

Young Living Sunscreen Receives Seal of Recommendation from The Skin Cancer Foundation

0
Young Living Sunscreen Receives Seal of Recommendation from The Skin Cancer Foundation

Young Living Essential Oils, the world leader in essential oils, announced today that its Mineral Sunscreen Lotion SPF 50 received the Seal of Recommendation from The Skin Cancer Foundation.

Lehi, Utah-baed Young Living’s Mineral Sunscreen meets the Foundation’s stringent criteria for safe and effective daily use broad spectrum (UVA and UVB) sun protection.

The Skin Cancer Foundation has set the standard for educating the public and the medical community about skin cancer, and focuses on decreasing the incidence and mortality of the world’s most common cancer. Occurring at epidemic levels, one in five Americans will develop skin cancer by the age of 70; and one person dies of melanoma, the most dangerous form of the disease, every hour.

To earn the Seal of Recommendation, a manufacturer must provide scientific data showing that its product adequately and safely “aids in the prevention of sun-induced damage to the skin.” The data is reviewed by a volunteer committee of photobiologists who are experts in the study of the interaction between ultraviolet radiation and the skin.

“When our scientists at Young Living formulated the Mineral Sunscreen, we wanted to offer people sun protection that doesn’t use harsh chemicals; and through our strict Seed to Seal process, we produced an effective, safe sunscreen that is genuine and pure for people of all ages,” said Dr. Michael Buch, Young Living Chief Science Officer. “We are proud that our Mineral Sunscreen will now carry The Skin Cancer Foundation’s Seal of Recommendation. (sflix.video) ”

Young Living’s Mineral Sunscreen Lotion SPF 50 is an over-the-counter, natural sunscreen that doesn’t contain chemical UV absorbers, making it a safe alternative for adults and kids.

Aurora Cannabis Closes $200-million Debt Facility with BMO

0
Aurora Cannabis Closes $200-million Debt Facility with BMO

Aurora Cannabis Inc. has closed a previously announced debt facility with the Bank of Montreal consisting of a $150-million term loan and a $50-million revolving credit facility, both of which mature in 2021.

Included in the facility is an option to upsize the facility to $250-million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.

The debt facility is primarily secured by Aurora’s production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie.

Strategically located at Edmonton International Airport, Aurora Sky is the world’s most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.

“With BMO and the syndicate lenders, Aurora gains significant runway to expansion opportunities that will positively contribute to our long-term margin profile and provide accelerated entry into multiple international markets,” said Terry Booth, CEO of Aurora.

“This additional capital positions us well to continue building the pre-eminent global cannabis company with a focus on vertically integrated, geographically and horizontally diversified assets.”

Headquartered in Edmonton, Aurora is one of the world’s largest and leading cannabis companies.

Supreme Cannabis Approved for Additional Production Capacity

0
Supreme Cannabis Approved for Additional Production Capacity

TheSupreme Cannabis Company has obtained Health Canada approval to commence cultivation on approximately 20,000 square feet of additional flowering rooms at its 7ACRES facility.

The additional flowering rooms will increase total potential flowering capacity to 90,000 square feet and, assuming a current yield, will bring 7ACRES’ annual production potential from 10,000kg to 13,330kg.

“As the first coast-to-coast premium cannabis brand in Canada, 7ACRES is already one of the fastest scaling producers in the country. This flowering room expansion continues to increase our capacity and improve our ability to meet the demand of cannabis enthusiasts upon legalization of adult use cannabis in Canada,” said John Fowler, CEO of Supreme Cannabis.

Completion of flowering rooms at the 342,000-square foot 7ACRES facility remains on schedule for completion in December 2018. With an annual production capacity expected to reach 50,000 kg once the 7ACRES facility is fully operational, the Company is committed to supplying premium-quality cannabis flower to the Canadian recreational market from coast-to-coast.

Visit www.supreme.ca and www.7ACRES.com for more information.

The Canadian Medical Association to support communities of interests

0
The Canadian Medical Association to support communities of interests

The Canadian Medical Association (CMA) has announced the five recipients of the CMA Communities of Interest Grant Program. Launched earlier this year, the program aims to support an existing community of interest, or to develop a new one by providing funding, strategic support and community management coaching.

The CMA is developing a virtual platform, where communities can be hosted and supported online. The platform, to be launched later this year, will enable community members across Canada to easily connect, share resources and join discussions in a virtual space. It will also provide physicians, stakeholders and patients ways to connect with the CMA to provide feedback on policies and programs.

 

The 2018 recipients are:

  • Indigenous Health: This community of interest will examine indigenous health inequities and ways of resolving these inequities on a personal, organizational and institutional level, in conjunction with First Nations communities.
  • Creating an Inclusive and Equitable Medical Community: This community of interest will focus on building an inclusive medical culture – sharing stories, resources and opportunities – with the goal of achieving gender equity in medical communities.
  • IMAGINE (Interprofessional and Medical Allied Groups Improving Neighbourhood Environments) Health: This community of interest will build on IMAGINE’s work, providing basic healthcare to marginalized people in Toronto by increasing awareness of patient access issues and sharing information about the resources available across Canada for vulnerable populations.
  • Canadian Association of MAID Assessors and Providers: This community of interest will develop an existing mailing list – run by CAMAP – into a broad, national forum to share experiences, resources and expertise.
  • Substance Use: This community of interest aims to build a national network on substance use issues where resources, expertise and experiences can be shared, as well as develop policy recommendations to inform municipal, provincial and federal governments on substance use.

Each of these communities are supported by groups of physicians and medical learners who want to bring together stakeholders looking to address these issues.

Thirty-two scientists awarded grants from CAMH Discovery Fund

0
Thirty-two scientists awarded grants from CAMH Discovery Fund

An antidote for post-traumatic stress disorder. A nasal spray for panic attacks. An increase in brain plasticity, described by one successful applicant as the ‘Holy Grail’ of brain disorder research.

These are just a few of the first 32 exciting projects being funded by the Centre of Addiction and Mental Health’s (CAMH) Discovery Fund. It was created in January 2018 through a $100 million gift from an anonymous donor, the largest donation to mental health in Canadian history. Described at the time by CAMH’s CEO, Dr. Catherine Zahn as “an injection of wild, wild hope,” the Discovery Fund will attract and develop top talent, and nurture the kind of cutting-edge research and innovation that can lead to true breakthroughs in mental health treatment and care.

“This is only the beginning,” said Dr. Vicky Stergiopoulos, CAMH’s physician-in-chief. “There is such an urgent need for better understanding and treatments for people with mental illness. Through the Discovery Fund, we are focused on discovery and innovation to improve outcomes for those we serve today, as well as future generations, both here in Canada, and around the world.”

After each project was rigorously reviewed and evaluated by a team of internal and external experts, seven were granted two-year Seed Funding awards of up to $200,000.

Another 25 applications to the Talent Development fund, created to assist and inspire the next generation of mental health researchers, were also given the green light.

“We were tremendously impressed with the variety of truly innovative projects presented to us,” said Dr. Tarek Rajji, deputy physician-in-chief for Research at CAMH. “These are all important studies that could have a powerful impact on mental health in Canada and globally and we’re proud to be able to fund them through the Discovery Fund. Being able to fund high-risk/high-reward studies could lead to paradigm shifts in mental health research.”

The gap between Canadians and digital health services

0
The gap between Canadians and digital health services

Canadians increasingly want access to digital health services, however there is a significant gap between this desire and their ability to access various services online.

Connecting Patients for Better Health 2018 draws on four public opinion surveys conducted for Canada Health Infoway between February 2014 and March 2018, and provides a picture of Canadians’ attitudes about and ability to access digital health services.

“Canadians deserve to be able to access their health information and services in the same way they access their financial services — online, at their convenience, and with assurance that the highest standards of privacy and security are in place,” said Michael Green, president and CEO of Infoway.

Currently, 22 per cent of Canadians have access to their health information online, while 73 per cent do not, and would like this access. The main digital services Canadians want are the ability to renew prescriptions, view their health information, book appointments with their family doctor, confirm specialist referrals and receive confirmations of specialist appointments, all online and preferably from the device of their choice.

Canadians who have access to digital health services say it is more convenient and improves their ability to manage their care. It also improves the timeliness of the care they receive, results in better communication with their health care provider, and makes them feel like partners with their care team.

Virtual visits — the ability to talk with their health care providers by video — is another digital service that interests Canadians. Forty-one per cent say they would like to access this service, while only six per cent can do so currently.

“Infoway’s bold new ACCESS Health initiative will make it quicker and easier for Canadians to access digital health services,” said Green. “Our goal is to provide all Canadians with access to a modern, 21st century health system that is sustainable, efficient, and, above all, improves their care experiences and health outcomes.”

Unauthorized skin creams and lotions sold at various retailers in Quebec may pose health risks

0
Unauthorized skin creams and lotions sold at various retailers in Quebec may pose health risks

Health Canada seized eight unauthorized skin lotions and creams from Ayotai Canada because they are labelled to contain a prescription drug (clobetasol propionate or betamethasone dipropionate). The unauthorized lotions and creams were distributed by Ayotai and sold by various retailers in Quebec.

Prescription drugs can only be dispensed by a healthcare professional to a patient with a valid prescription. The products listed below have not been evaluated by Health Canada for safety, effectiveness or quality, and may pose serious health risks.

 

Who is affected

  • Consumers who have bought or used these products, particularly pregnant or nursing women.

 

Affected products

  • Betasol Cream: clobetasol propionate 0.05 per cent
  • Betasol Lotion: clobetasol propionate 0.05 per cent
  • Diproson Cream: betamethasone dipropionate
  • Haloderm: clobetasol propionate 0.05 per cent
  • L’abdijanaise Cream: clobetasol propionate 0.05 per cent
  • Lemonvate Cream: clobetasol propionate 0.05 per cent
  • Natural Papaya Cream: clobetasol propionate 0.05 per cent
  • Nature Secrète Cream: clobetasol propionate 0.05 per cent

 

What consumers should do

  • Do not use these products. Consult with your health care professional if you have used any of these products and have health concerns.
  • Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada’s Drug Product Database and Licensed Natural Health Product Database.
  • Report adverse events to health products to Health Canada by calling toll-free at 1-866-234-2345, or by reporting online, by mail or by fax.
  • Report complaints about health products to Health Canada by calling toll-free at 1-800-267-9675, or complete an online complaint form.

 

What Health Canada is doing
Health Canada has seized the products from the company warehouse and has requested the company recall the products already distributed. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.

 

Background
Clobetasol propionate
is a highly potent topical (applied to the skin) corticosteroid prescription drug used to treat inflammatory skin conditions. It should be used only under the supervision of a health care professional. Side effects include skin irritation, weakening or deterioration. Topical corticosteroids can be absorbed in sufficient amounts to produce adverse effects, including symptoms of adrenal suppression (low blood pressure, low blood sugar, weight loss, muscle pain, gastrointestinal problems, and severe fatigue) or Cushing’s syndrome (high blood pressure, high blood sugar, weight gain, muscle weakness, bone loss, and severe fatigue) depending on how much has been absorbed. Clobetasol should not be used by pregnant or nursing women.

Betamethasone dipropionate is a highly potent corticosteroid prescription drug that can be used topically (applied to the skin) to treat inflammatory skin conditions. It should be used only under the supervision of a health care professional. Side effects from topical use include skin irritation and, with prolonged use, skin weakening or deterioration. Topical corticosteroids can be absorbed in sufficient amounts to produce adverse effects, including symptoms of adrenal suppression (low blood pressure, low blood sugar, weight loss, muscle pain, gastrointestinal problems, and severe fatigue) or Cushing’s syndrome (high blood pressure, high blood sugar, weight gain, muscle weakness, bone loss, and severe fatigue) depending on how much has been absorbed. Betamethasone dipropionate should not be used by pregnant or nursing women.

The Big Carrot takes on the Beaches

0
The Big Carrot takes on the Beaches

The Big Carrot has been an establishment in the Danforth community for 35 years. It has been a place where customers who are looking for organic, non-GMO, and local products can come and be satisfied every time.

After being so successful for more than three decades, it only made sense to open a new location and continue to grow in another community.

On June 21, The Big Carrot’s second location opened at 125 Southwood Dr. at the corner of Kingston Road and Main Street in the Beaches community.

“Since then it has been really amazing, we’re really enjoying being in a new neighbourhood,” said Sarah Dobec, the marketing manager at The Big Carrot. “The customer base is similar but it’s been so nice getting to know our new neighbours and learning their preferences.”

Along with a new location, The Big Carrot has also introduced new brand identity, which “evokes the heritage, experience and expertise already engrained into the DNA of the existing brand,” as stated in The Big Carrot press release. “It is reflective of exciting, new beginnings, as well as our humble inception,” the release concluded.

The Big Carrot was the first of its kind in 1983, being a health food store that offered one-stop shopping with a vegetarian deli, bulk foods, organic produce and a selection on wholesome groceries. Since then, the organic industry has been growing rapidly, “We see a lot of competition in other small retailers and even bigger box stores; the organic food demand is definitely there,” Dobec explained. “However, our store is unique, we’re really proud of our food standards and the products in our store. Our customers know that we really live up to those standards.”

Dobec continued to express her hopes for the future of the store, “The customers on the Danforth really built a community around the store, and we hope to duplicate that with our Beaches community, and will continue to expand and open more stores. The community we’ve built, it’s really unique.”

The Beach Community Market is approximately 6,000 sq. ft. and offers the same departments as the Danforth location, focusing on fresh ‘grab ‘n go’ foods, an organic smoothie/coffee bar, and a smaller selection of grocery, personal care, and dispensary items. This location will also prohibit the sale of single-use plastic water bottles, 2L and under.